CD86 and acute myeloid leukemia: However, the AML subgroups did not significantly differ in macrophage activation upon knockdown of STAT1, as the amounts of CD11b+CD68+ CD86+ and CD11b+CD68+ CD40+ cells in AML subgroups remained unchanged in the presence of fludarabine or STAT1 siRNA.